Latest News about Market/Moving Exclusives
Recent news which mentions Market/Moving Exclusives
From Benzinga
EXCLUSIVE: Oragenics' Concussion Drug Clears FDA-Required Cardiotoxicity Testing, Planning For Phase Trials Underway
August 08, 2024
From Benzinga
EXCLUSIVE: Penny Stock Conduit Pharmaceuticals Inks Licensing Pact With AstraZeneca For Multiple Assets
August 08, 2024
From Benzinga
EXCLUSIVE: Adial Pharmaceuticals' Last Patient Dosed in Pharmacokinetics Study of AD04 For Alcohol Use Disorder, Data Expected In Q4
August 07, 2024
From Benzinga
EXCLUSIVE: Janover's Groundbreaker Achieves 64% Profit Margin, Second Consecutive Month of Profitability
August 07, 2024
From Benzinga
Exclusive: Healthcare Service Provider Scorpius Surpasses $100M In Business Opportunities, Eyes Revenue Boost
August 06, 2024
From Benzinga
EXCLUSIVE: Alzamend Neuro To Assess AL001 Alzheimer's Candidate Against Commonly Marketed Lithium Salt In Phase 2 Head-To-Head Study
August 05, 2024
From Benzinga
From Benzinga
EXCLUSIVE: Artificial Intelligence-Based Advertising Firm Inuvo Securing $10M Credit Line, Strengthens Financial Position
July 31, 2024
From Benzinga
From Benzinga
EXCLUSIVE: La Rosa Announces Plans to Acquire Celebration Corporate Center, Boosting Real Estate Presence
July 24, 2024
From Benzinga
EXCLUSIVE: Perfect Corp's Q2 Revenue Jumps 9.6%, YouCam App Subscribers Hit Record High
July 24, 2024
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.